Ixabepilone (Bms-247550) Plus Trastuzumab Combination Chemotherapy Induces Synergistic Antitumor Efficacy In Her2 Dependent Breast Cancers And Is Accompanied By Modulation Of Molecular Response Markers.
JOURNAL OF CLINICAL ONCOLOGY（2005）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要